WebBlue Lake Biotechnology data provided by Blue Lake Biotechnology Private Company Company Overview Blue Lake Biotechnology is a startup company that focuses on … WebSep 27, 2024 · ATHENS, Ga. and LOS ALTOS, Calif., Sept. 27, 2024 /PRNewswire/ -- CyanVac LLC and its subsidiary, Blue Lake Biotechnology, Inc., clinical-stage biopharmaceutical companies developing vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector, today announced the enrollment of the first …
Blue Lake Biotechnology LinkedIn
WebBLUE LAKE BIOTECHNOLOGY, INC. CALIFORNIA STOCK CORPORATION - OUT OF STATE - STOCK: WRITE REVIEW: Address: 111 Riverbend Road Athens, GA 30602: Registered Agent: Paracorp Incorporated: Filing Date: January 05, 2024: File Number: 4684832: Contact Us About The Company Profile For Blue Lake Biotechnology, Inc. WebNov 7, 2024 · Blue Lake Biotechnology and CyanVac LLC are developing BLB201 as a single dose, intranasal vaccine to prevent acute and severe disease associated with … can you eat cold lunch meat when pregnant
Blue Lake Biotechnology - Overview, News & Competitors
WebNov 7, 2024 · CyanVac LLC and its subsidiary, Blue Lake Biotechnology, Inc., are technology-driven companies developing lifesaving intranasal vaccines based on a proprietary PIV5-based vaccine platform licensed from the University of Georgia. Our COVID-19 and RSV vaccine programs are in Phase 1 clinical trials. WebBiotechnology Health Care Life Science Headquarters Regions East Coast, Southern US Founded Date 2024 Founders Biao He Operating Status Active Last Funding Type Venture - Series Unknown Legal Name … WebNov 7, 2024 · Athens, GA and Los Gatos, CA, November 7, 2024.Blue Lake Biotechnology, Inc., a clinical-stage biotechnology company developing intranasal vaccines using a proprietary parainfluenza virus 5 (PIV5)-based vector, announced preliminary interim data today from a phase 1 clinical trial of its BLB201 vaccine for … brightfocal screen replacement